StrideBio and Takeda Sign Collaboration and License Agreement to Advance Novel Gene Therapies for…
StrideBio announced the signing of a collaboration and license agreement with Takeda Pharmaceutical Company Limited (Takeda) to develop in vivo AAV based therapies for Friedreich's…
Read More...
Read More...
